Related references
Note: Only part of the references are listed.Embryonic Expression of NrasG 12 D Leads to Embryonic Lethality and Cardiac Defects
Xiaona You et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment
Lea Linglart et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2020)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases
Antonella Fiordelisi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Epac Function and cAMP Scaffolds in the Heart and Lung
Marion Laudette et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2018)
Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart
Kristina Lorenz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
Seung-Min Shin et al.
NATURE COMMUNICATIONS (2017)
Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal- regulated kinases signaling pathway in spontaneously hypertensive rats
Xingjiang Xiong et al.
SCIENTIFIC REPORTS (2017)
H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT
Takahisa Matsuda et al.
CIRCULATION-HEART FAILURE (2017)
Impaired synaptic plasticity in RASopathies: a mini-review
Florian Mainberger et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Comparison of the Conformations of KRAS Isoforms, K-Ras4A and K-Ras4B, Points to Similarities and Significant Differences
Mayukh Chakrabarti et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2016)
RAS/Effector Interactions from Structural and Biophysical Perspective
Ariel Erijman et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1
Jonathan M. Payne et al.
NEUROLOGY (2016)
Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies
Won Kyoung Jhang et al.
PEDIATRIC CARDIOLOGY (2016)
Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling
Chen-Ze Zhao et al.
SCIENTIFIC REPORTS (2016)
A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
Carrie E. Bearden et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham et al.
ARCHIVES OF TOXICOLOGY (2015)
Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy
Manuel Ramos-Kuri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats
Wei-wei Wang et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2015)
Enhanced Cardiac Akt/Protein Kinase B Signaling Contributes to Pathological Cardiac Hypertrophy in Part by Impairing Mitochondrial Function via Transcriptional Repression of Mitochondrion-Targeted Nuclear Genes
Adam R. Wende et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Carabin Protects Against Cardiac Hypertrophy by Blocking Calcineurin, Ras, and Ca2+/Calmodulin-Dependent Protein Kinase II Signaling
Malik Bisserier et al.
CIRCULATION (2015)
Intracellular antibody capture: A molecular biology approach to inhibitors of protein-protein interactions
Jing Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Cyclic AMP synthesis and hydrolysis in the normal and failing heart
Aziz Guellich et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
K-RasV14I recapitulates Noonan syndrome in mice
Isabel Hernandez-Porras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cardiac Findings in Noonan Syndrome on Long-term Follow-up
John L. Colquitt et al.
CONGENITAL HEART DISEASE (2014)
Cardiac characterization of 16 patients with large NF1 gene deletions
R. Nguyen et al.
CLINICAL GENETICS (2013)
Molecular targets of current and prospective heart failure therapies
Elie R. Chemaly et al.
HEART (2013)
Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats
Xia Li et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
被撤回的出版物: A Cardiac-enriched MicroRNA, miR-378, Blocks Cardiac Hypertrophy by Targeting Ras Signaling(Retracted article. See vol. 292, pg. 5123, 2017)
Raghu S. Nagalingam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin
Elie R. Chemaly et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Molecular basis of physiological heart growth: fundamental concepts and new players
Marjorie Maillet et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Stimulation of α1a Adrenergic Receptors Induces Cellular Proliferation or Antiproliferative Hypertrophy Dependent Solely on Agonist Concentration
Beilei Lei et al.
PLOS ONE (2013)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications
Y-F Lau et al.
JOURNAL OF HUMAN HYPERTENSION (2012)
Signaling to Cardiac Hypertrophy: Insights from Human and Mouse RASopathies
Valentina Sala et al.
MOLECULAR MEDICINE (2012)
Clinical, Pathological, and Molecular Analyses of Cardiovascular Abnormalities in Costello Syndrome: A Ras/MAPK Pathway Syndrome
Angela E. Lin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Toshinori Aoyagi et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Inhibition of Ras for cancer treatment: the search continues
Antonio T. Baines et al.
FUTURE MEDICINAL CHEMISTRY (2011)
RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it
Bruce D. Gelb et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation
Xue Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation
Talita M. Marin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cardiac gene therapy with SERCA2a: From bench to bedside
Judith K. Gwathmey et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes
Perundurai S. Dhandapany et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Therapeutic Levels of the Hydroxmethylglutaryl-Coenzyme A Reductase Inhibitor Lovastatin Activate Ras Signaling via Phospholipase D2
Kwang-jin Cho et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure
Larissa Lipskaia et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents
Ippei Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Effects of Angiotensin Type I Receptor Blockade on the Cardiac Raf/MEK/ERK Cascade Activated via Adrenergic Receptors
Guo-Xing Zhang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
A restricted spectrum of NRAS mutations causes Noonan syndrome
Ion C. Cirstea et al.
NATURE GENETICS (2010)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
Cardiomyocyte-Specific Loss of Neurofibromin Promotes Cardiac Hypertrophy and Dysfunction
Junwang Xu et al.
CIRCULATION RESEARCH (2009)
The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch
Nicolas Duquesnes et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Mechanotransduction gone awry
Diana E. Jaalouk et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts
Gabriella F. Kocsis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Epac mediates β-adrenergic receptor-induced cardiomyocyte hypertrophy
Melanie Metrich et al.
CIRCULATION RESEARCH (2008)
Small GTP-binding proteins and their regulators in cardiac hypertrophy
Frank Lezoualc'h et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes
Yanni Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Kras and Hras - what is the difference?
Anton Berns
NATURE GENETICS (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Partial functional overlap of the three ras genes in mouse embryonic development
K. Nakamura et al.
ONCOGENE (2008)
Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome
A. L. Schulz et al.
CLINICAL GENETICS (2008)
Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy
Coskun Ulucan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features
Oddmund Sovik et al.
JOURNAL OF MEDICAL GENETICS (2007)
Treatment of heart failure by calcium cycling gene therapy
Larissa Lipskaia et al.
FUTURE CARDIOLOGY (2007)
Cardioprotection from ischemia-reperfusion injury due to Ras-GTPase inhibition is attenuated by glibenclamide in the globally ischemic heart
Ibrahim Al-Rashdan et al.
CELL BIOCHEMISTRY AND FUNCTION (2007)
The fuzzy logic of physiological cardiac hypertrophy
Gerald W. Dorn
HYPERTENSION (2007)
Differences between pathological and physiological cardiac hypertrophy: Novel therapeutic strategies to treat heart failure
Julie R. McMullen et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies
PM LoRusso et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice
N Potenza et al.
EMBO REPORTS (2005)
The Ras superfamily at a glance
K Wennerberg et al.
JOURNAL OF CELL SCIENCE (2005)
Stress-activated MAP kinases in cardiac remodeling and heart failure new insights from transgenic studies
BG Petrich et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2004)
Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload
IS Harris et al.
CIRCULATION (2004)
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart
MZ Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
O Yamaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Ras proteins: Different signals from different locations
JF Hancock
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Differences on the inhibitory Specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane Microlocalization
D Matallanas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rheb fills a GAP between TSC and TOR
BD Manning et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Ras/Erk signaling is essential for activation of protein synthesis by Gq protein receptor agonists in adult cardiomyocytes
LJ Wang et al.
CIRCULATION RESEARCH (2002)
Hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation
C Indolfi et al.
CIRCULATION (2002)
PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy
AL Bayer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Integrins play a critical role in mechanical stress-induced p38 MAPK activation
R Aikawa et al.
HYPERTENSION (2002)
Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy
D Lebeche et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2001)
Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development
LM Esteban et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Ras regulates NFAT3 activity in cardiac myocytes
M Ichida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Calcineurin and beyond - Cardiac hypertrophic signaling
JD Molkentin
CIRCULATION RESEARCH (2000)
Cardiac signal transduction
KH Lee et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2000)
Share Paper
